Pharmaceutical industry – Page 48

Business
DSM to spin out pharma unit

2013-11-22T00:00:00Z

Firm will combine with Patheon to provide manufacturing services
Business
Novartis sells off blood diagnostics division

2013-11-14T00:00:00Z

$1.7bn deal reinforces firm’s focus on core pharmaceuticals
Careers
The pain killer

2013-11-13T00:00:00Z

Life is pretty painless working in Reckitt Benckiser’s Nurofen team, Sarah Houlton learns
Business
Shire will cut UK R&D to focus on rare diseases

2013-11-11T00:00:00Z

$4.2bn buyout of ViroPharma bolsters pipeline, while Basingstoke site halts research
Business
Mis-selling lands J&J with $2.2bn fine

2013-11-11T00:00:00Z

Company found guilty of promoting three drugs for unapproved uses
Business
Novartis to shut Horsham site

2013-11-06T00:00:00Z

UK research centre closure to result in the loss of 371 jobs as firm consolidates its global R&D base
Opinion
Natural born chemists

2013-10-31T00:00:00Z

Redesigning nature’s catalysts is tantalising but tricky, says Derek Lowe
Business
Vertex to cut 370 jobs

2013-10-30T00:00:00Z

Imminent competition drives drop in its hepatitis C drug’s performance
Business
AstraZeneca to close environmental lab and cut 71 jobs

2013-10-25T00:00:00Z

Environmental impact services will be outsourced after Devon lab closes in March 2014
Business
Pharma manufacturing woes dog industry

2013-10-23T00:00:00Z

Regulators are stepping up inspections, and discovering ever more problems
Business
Counterfeit anxiety pills seized in Switzerland

2013-10-21T00:00:00Z

1 million fake tablets were en route from China to Egypt
Business
Roche backs biologics boom

2013-10-15T00:00:00Z

Swiss firm to invest heavily in manufacturing for complex biological drugs
Business
5000 jobs to be cut at Teva

2013-10-14T00:00:00Z

Generics giant aims to cut costs and reinvest in R&D
Business
GSK to apply for malaria vaccine approval

2013-10-09T00:00:00Z

Infection protection drops over time, but the firm will go ahead with regulatory submission
Business
Lundbeck cuts jobs in Europe, but expands in US

2013-10-04T00:00:00Z

Depression drug approval fuels US recruitment
Business
Amid huge cuts, Merck vows research focus

2013-10-04T00:00:00Z

8500 more jobs to be axed, but the drugmaker ‘remains committed to innovation’
Business
Aspen acquires anticoagulant brands

2013-10-02T00:00:00Z

South African drugmaker buys thrombosis drugs from GSK for £700m
Business
Japan confirms Novartis clinical trial data fabrication

2013-10-01T00:00:00Z

Investigation into blood pressure blockbuster continues
Business
New respiratory drugs neck and neck

2013-09-25T00:00:00Z

Combination inhalers from GSK and Novartis approved in EU and Japan
Business
Nanobody inflammation drug attracts Abbvie

2013-09-25T00:00:00Z

$840m licensing deal shows support for antibody fragments